The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Boerner Christopher S. since 2019.
This trader's CIK number is 1543747.
At the time of last reporting, Boerner Christopher S. was the Chief Executive Officer of Bristol Myers Squibb Co. (stock ticker symbol BMY).
Also see all insider trading activities at Bristol Myers Squibb Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BMY | 2,000 | $110,096 | 0 | $0 | 62,998 | $0 |
| 2024 | BMY | 0 | $0 | 0 | $0 | 57,602 | $0 |
| 2023 | BMY | 5,071 | $249,609 | 0 | $0 | 61,749 | $0 |
| 2022 | BMY | 0 | $0 | 29,532 | $2,043,525 | 54,352 | $0 |
| 2021 | BMY | 0 | $0 | 0 | $0 | 27,853 | $0 |
| 2020 | BMY | 0 | $0 | 0 | $0 | 24,063 | $0 |
| 2019 | BMY | 0 | $0 | 0 | $0 | 20,172 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-01 | BMY | Option Ex | 2,964 | .00 | 0 |
| 2025-03-10 | BMY | Option Ex | 60,034 | .00 | 0 |
| 2025-02-20 | BMY | Buy | 2,000 | 55.05 | 110,096 |
| 2024-11-01 | BMY | Option Ex | 2,964 | .00 | 0 |
| 2024-03-10 | BMY | Option Ex | 54,638 | .00 | 0 |
| 2023-12-05 | BMY | Buy | 2,000 | 49.78 | 99,560 |
| 2023-12-02 | BMY | Option Ex | 2,638 | .00 | 0 |
| 2023-11-28 | BMY | Buy | 3,071 | 48.86 | 150,049 |
| 2023-03-10 | BMY | Option Ex | 59,111 | .00 | 0 |
| 2022-12-02 | BMY | Option Ex | 2,637 | .00 | 0 |
| 2022-03-14 | BMY | Sale | 29,532 | 69.20 | 2,043,525 |
| 2022-03-10 | BMY | Option Ex | 51,715 | .00 | 0 |
| 2021-12-02 | BMY | Option Ex | 2,638 | .00 | 0 |
| 2021-03-10 | BMY | Option Ex | 25,215 | .00 | 0 |
| 2020-12-02 | BMY | Option Ex | 2,637 | .00 | 0 |
| 2020-03-10 | BMY | Option Ex | 21,426 | .00 | 0 |
| 2019-03-10 | BMY | Option Ex | 15,707 | .00 | 0 |
| 2019-02-02 | BMY | Option Ex | 4,465 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Boerner Christopher S. (Chief Executive Officer of Bristol Myers Squibb Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.